The pharmaceutical industry has reached a historic inflection point. For years, the oncology juggernaut Keytruda (pembrolizumab) has...
Treatment Innovations
In a landmark deal that underscores the seismic shift occurring within the pharmaceutical industry, Insilico Medicine has...
In a significant strategic reversal, Becton Dickinson and Company (BD) has announced an upward revision to its...
In the rapidly evolving landscape of drug discovery, the quest for high-resolution protein structures has long been...
As the global healthcare landscape faces the dual pressures of an aging population and increasingly complex clinical...
In the high-stakes arena of global biopharmaceuticals, cash is king, but timing is everything. As Eli Lilly...
The landscape of robotic-assisted surgery is undergoing a seismic shift, particularly in the delicate realm of super-microsurgery....
Executive Summary: A Resilient Financial Outlook In a defining moment for the global metabolic health sector, Danish...
The landscape of global pharmaceutical development is undergoing a tectonic shift. In a remarkable demonstration of rapid...
In a landmark decision that promises to reshape the landscape of urological oncology, the UK’s National Institute...
